Also trades as: PPBT.TA (TLV) · $vol 0M
PPBT NASDAQ
Purple Biotech Ltd.
1W: +0.0%
1M: -23.7%
3M: -12.7%
YTD: -77.1%
1Y: +157.7%
3Y: -93.4%
5Y: -98.4%
$1.51
-0.01 (-0.66%)
Weekly Expected Move ±9.6%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$6M
+61.5% ▲
Capital Expenditures
$3K
+0.0% ▲
5Y CAGR: -54.6%
Free Cash Flow
-$6M
+61.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+118.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$18M | -$22M | -$20M | -$7M | -$27M |
| Depreciation & Amort. | $231K | $201K | $197K | $186K | $0 |
| Stock-Based Comp. | $2M | $2M | $2M | $582K | $0 |
| Change in Working Capital | $550K | $3M | $274K | -$4M | $814K |
| Other Non-Cash Items | -$108K | -$843K | -$2M | -$4M | $20M |
| Operating Cash Flow | -$15M | -$17M | -$20M | -$14M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$115K | -$228K | -$3K | $0 | -$3K |
| Acquisitions (Net) | $0 | $0 | -$4M | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $13M | $20M | $17M | $189K | $453K |
| Other Investing | $359K | $324K | $755K | $320K | $0 |
| Investing Cash Flow | $13M | $20M | $14M | $509K | $450K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$153K | -$165K | -$168K | -$183K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1M | -$219K | $4M | $1M | -$219K |
| Financing Cash Flow | $2M | $1M | $5M | $7M | $6M |
| Net Change in Cash | -$357K | $4M | -$541K | -$7M | $1M |
| Cash End of Period | $11M | $15M | $14M | $7M | $9M |
| Free Cash Flow | -$15M | -$17M | -$20M | -$14M | -$6M |